244 related articles for article (PubMed ID: 11669508)
61. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
Kaduszkiewicz H; Zimmermann T; Beck-Bornholdt HP; van den Bussche H
BMJ; 2005 Aug; 331(7512):321-7. PubMed ID: 16081444
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Hansen RA; Gartlehner G; Webb AP; Morgan LC; Moore CG; Jonas DE
Clin Interv Aging; 2008; 3(2):211-25. PubMed ID: 18686744
[TBL] [Abstract][Full Text] [Related]
63. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
64. Editorial comment--How to treat vascular dementia?
Bonelli RM
Stroke; 2003 Oct; 34(10):2331-2. PubMed ID: 14500926
[No Abstract] [Full Text] [Related]
65. Unsafe prescription medication switching recommendations.
Subbiah P; Schwam EM
Clin Ther; 2001 Dec; 23(12):2050-5. PubMed ID: 11813938
[No Abstract] [Full Text] [Related]
66. Cholinesterase inhibitors for Alzheimer's disease.
Grutzendler J; Morris JC
Drugs; 2001; 61(1):41-52. PubMed ID: 11217870
[TBL] [Abstract][Full Text] [Related]
67. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
Raina P; Santaguida P; Ismaila A; Patterson C; Cowan D; Levine M; Booker L; Oremus M
Ann Intern Med; 2008 Mar; 148(5):379-97. PubMed ID: 18316756
[TBL] [Abstract][Full Text] [Related]
68. Maintaining cognitive function in Alzheimer disease: how effective are current treatments?
Tariot PN
Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S26-33. PubMed ID: 11669506
[TBL] [Abstract][Full Text] [Related]
69. [Anticholinesterase agents in Alzheimer's disease].
Ventura M; Sternon J
Rev Med Brux; 2001 Sep; 22(4):A387-93. PubMed ID: 11680206
[TBL] [Abstract][Full Text] [Related]
70. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
[TBL] [Abstract][Full Text] [Related]
71. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
72. The pharmacology of donepezil: a new treatment of Alzheimer's disease.
Wilkinson DG
Expert Opin Pharmacother; 1999 Nov; 1(1):121-35. PubMed ID: 11249555
[TBL] [Abstract][Full Text] [Related]
73. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
74. [Current therapy of patients with dementia].
Fuchsberger T; Möller HJ; Hampel H
MMW Fortschr Med; 2003 May; 145 Suppl 2():49-52, 54. PubMed ID: 14579485
[TBL] [Abstract][Full Text] [Related]
75. [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Voss B; Thienel R; Leucht S; Kircher T
Nervenarzt; 2008 Jan; 79(1):47-8, 50-2, 54-9. PubMed ID: 17960354
[TBL] [Abstract][Full Text] [Related]
76. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Jann MW; Shirley KL; Small GW
Clin Pharmacokinet; 2002; 41(10):719-39. PubMed ID: 12162759
[TBL] [Abstract][Full Text] [Related]
77. Drugs for cognitive loss and dementia.
Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
[TBL] [Abstract][Full Text] [Related]
78. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
Capellà D; Vidal X
Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086
[No Abstract] [Full Text] [Related]
79. [Advances in Alzheimer's disease treatment].
Nourhashémi F
Rev Med Interne; 2006 Aug; 27(8):585-7. PubMed ID: 16782240
[No Abstract] [Full Text] [Related]
80. The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action.
Stahl SM
J Clin Psychiatry; 2000 Nov; 61(11):813-4. PubMed ID: 11105732
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
